• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重新评估脂肪酸受体 1 作为人类刺激胰岛素分泌的药物靶点。

Reevaluation of fatty acid receptor 1 as a drug target for the stimulation of insulin secretion in humans.

机构信息

University of Tübingen, Department of Internal Medicine IV, Division of Endocrinology, Diabetology, Vascular Medicine, Nephrology and Clinical Chemistry, Tübingen, Germany.

出版信息

Diabetes. 2013 Jun;62(6):2106-11. doi: 10.2337/db12-1249. Epub 2013 Feb 1.

DOI:10.2337/db12-1249
PMID:23378609
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3661642/
Abstract

The role of free fatty acid receptor 1 (FFAR1/GPR40) in glucose homeostasis is still incompletely understood. Small receptor agonists stimulating insulin secretion are undergoing investigation for the treatment of type 2 diabetes. Surprisingly, genome-wide association studies did not discover diabetes risk variants in FFAR1. We reevaluated the role of FFAR1 in insulin secretion using a specific agonist, FFAR1-knockout mice and human islets. Nondiabetic individuals were metabolically phenotyped and genotyped. In vitro experiments indicated that palmitate and a specific FFAR1 agonist, TUG-469, stimulate glucose-induced insulin secretion through FFAR1. The proapoptotic effect of chronic exposure of β-cells to palmitate was independent of FFAR1. TUG-469 was protective, whereas inhibition of FFAR1 promoted apoptosis. In accordance with the proapoptotic effect of palmitate, in vivo cross-sectional observations demonstrated a negative association between fasting free fatty acids (NEFAs) and insulin secretion. Because NEFAs stimulate secretion through FFAR1, we examined the interaction of genetic variation in FFAR1 with NEFA and insulin secretion. The inverse association of NEFA and secretion was modulated by rs1573611 and became steeper for carriers of the minor allele. In conclusion, FFAR1 agonists support β-cell function, but variation in FFAR1 influences NEFA effects on insulin secretion and therefore could affect therapeutic efficacy of FFAR1 agonists.

摘要

游离脂肪酸受体 1(FFAR1/GPR40)在葡萄糖稳态中的作用仍不完全清楚。正在研究刺激胰岛素分泌的小受体激动剂,以用于治疗 2 型糖尿病。令人惊讶的是,全基因组关联研究并未在 FFAR1 中发现糖尿病风险变异。我们使用特定激动剂、FFAR1 敲除小鼠和人胰岛重新评估了 FFAR1 在胰岛素分泌中的作用。对非糖尿病个体进行代谢表型和基因型分析。体外实验表明,棕榈酸和特定的 FFAR1 激动剂 TUG-469 通过 FFAR1 刺激葡萄糖诱导的胰岛素分泌。β 细胞长期暴露于棕榈酸的促凋亡作用与 FFAR1 无关。TUG-469 具有保护作用,而 FFAR1 的抑制则促进凋亡。与棕榈酸的促凋亡作用一致,体内横断面观察表明空腹游离脂肪酸(NEFAs)与胰岛素分泌呈负相关。由于 NEFAs 通过 FFAR1 刺激分泌,我们研究了 FFAR1 中的遗传变异与 NEFA 和胰岛素分泌之间的相互作用。rs1573611 调节了 NEFA 与分泌之间的反向关联,并且携带次要等位基因的个体的关联变得更加陡峭。总之,FFAR1 激动剂支持β细胞功能,但 FFAR1 的变异影响 NEFA 对胰岛素分泌的影响,因此可能会影响 FFAR1 激动剂的治疗效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f60e/3661642/3aa95ee12684/2106fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f60e/3661642/45c615a17a6d/2106fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f60e/3661642/3aa95ee12684/2106fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f60e/3661642/45c615a17a6d/2106fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f60e/3661642/3aa95ee12684/2106fig2.jpg

相似文献

1
Reevaluation of fatty acid receptor 1 as a drug target for the stimulation of insulin secretion in humans.重新评估脂肪酸受体 1 作为人类刺激胰岛素分泌的药物靶点。
Diabetes. 2013 Jun;62(6):2106-11. doi: 10.2337/db12-1249. Epub 2013 Feb 1.
2
Activation of extracellular signal-regulated protein kinases 1 and 2 (ERK1/2) by free fatty acid receptor 1 (FFAR1/GPR40) protects from palmitate-induced beta cell death, but plays no role in insulin secretion.游离脂肪酸受体1(FFAR1/GPR40)对细胞外信号调节蛋白激酶1和2(ERK1/2)的激活可保护β细胞免受棕榈酸酯诱导的细胞死亡,但对胰岛素分泌无作用。
Cell Physiol Biochem. 2015;35(4):1537-45. doi: 10.1159/000373969. Epub 2015 Mar 12.
3
Point mutation of Ffar1 abrogates fatty acid-dependent insulin secretion, but protects against HFD-induced glucose intolerance.FFAR1 点突变可消除脂肪酸依赖性胰岛素分泌,但可预防 HFD 诱导的葡萄糖不耐受。
Mol Metab. 2017 Oct;6(10):1304-1312. doi: 10.1016/j.molmet.2017.07.007. Epub 2017 Jul 18.
4
Glucose-stimulated insulin secretion depends on FFA1 and Gq in neonatal mouse islets.葡萄糖刺激的胰岛素分泌依赖于新生鼠胰岛中的 FFA1 和 Gq。
Diabetologia. 2023 Aug;66(8):1501-1515. doi: 10.1007/s00125-023-05932-5. Epub 2023 May 23.
5
Basal hypersecretion of glucagon and insulin from palmitate-exposed human islets depends on FFAR1 but not decreased somatostatin secretion.棕榈酸暴露的人胰岛中胰高血糖素和胰岛素的基础分泌亢进依赖于 FFAR1,但不依赖于生长抑素分泌减少。
Sci Rep. 2017 Jul 5;7(1):4657. doi: 10.1038/s41598-017-04730-5.
6
FFAR1 is involved in both the acute and chronic effects of palmitate on insulin secretion.FFAR1 参与棕榈酸对胰岛素分泌的急性和慢性作用。
Endocrinology. 2013 Nov;154(11):4078-88. doi: 10.1210/en.2013-1352. Epub 2013 Sep 13.
7
20-HETE promotes glucose-stimulated insulin secretion in an autocrine manner through FFAR1.20-羟基二十碳四烯酸(20-HETE)通过游离脂肪酸受体1(FFAR1)以自分泌方式促进葡萄糖刺激的胰岛素分泌。
Nat Commun. 2018 Jan 12;9(1):177. doi: 10.1038/s41467-017-02539-4.
8
Free fatty acid receptor 1 (FFAR1/GPR40) signaling affects insulin secretion by enhancing mitochondrial respiration during palmitate exposure.游离脂肪酸受体1(FFAR1/GPR40)信号传导通过在棕榈酸暴露期间增强线粒体呼吸来影响胰岛素分泌。
Biochim Biophys Acta. 2015 Dec;1853(12):3248-57. doi: 10.1016/j.bbamcr.2015.09.022. Epub 2015 Sep 25.
9
Lack of GPR40/FFAR1 does not induce diabetes even under insulin resistance condition.缺乏 GPR40/FFAR1 即使在胰岛素抵抗的情况下也不会导致糖尿病。
Diabetes Obes Metab. 2013 Jun;15(6):538-45. doi: 10.1111/dom.12065. Epub 2013 Feb 6.
10
β-Arrestin Recruitment and Biased Agonism at Free Fatty Acid Receptor 1.β-抑制蛋白在游离脂肪酸受体1上的募集及偏向性激动作用
J Biol Chem. 2015 Aug 21;290(34):21131-21140. doi: 10.1074/jbc.M115.644450. Epub 2015 Jul 8.

引用本文的文献

1
CARDIAL-MS (CArdio-Renal-DIAbetes-Liver-Metabolic Syndrome): a new proposition for an integrated multisystem metabolic disease.心脏-肾脏-糖尿病-肝脏-代谢综合征(CARDIAL-MS):一种综合多系统代谢疾病的新定义。
Diabetol Metab Syndr. 2025 Jun 16;17(1):218. doi: 10.1186/s13098-025-01796-4.
2
Mechanism of Obesity-Related Lipotoxicity and Clinical Perspective.肥胖相关脂毒性的机制及临床观点。
Adv Exp Med Biol. 2024;1460:131-166. doi: 10.1007/978-3-031-63657-8_5.
3
Glucose-stimulated insulin secretion depends on FFA1 and Gq in neonatal mouse islets.

本文引用的文献

1
Structure-Activity Study of Dihydrocinnamic Acids and Discovery of the Potent FFA1 (GPR40) Agonist TUG-469.二氢肉桂酸的构效关系研究及强效游离脂肪酸受体1(GPR40)激动剂TUG-469的发现。
ACS Med Chem Lett. 2010 Jul 2;1(7):345-9. doi: 10.1021/ml100106c. eCollection 2010 Oct 14.
2
Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways.大规模的关联分析确定了影响血糖特征的新基因座,并深入了解了潜在的生物学途径。
Nat Genet. 2012 Sep;44(9):991-1005. doi: 10.1038/ng.2385. Epub 2012 Aug 12.
3
Higher fasting plasma free fatty acid levels are associated with lower insulin secretion in children and adults and a higher incidence of type 2 diabetes.
葡萄糖刺激的胰岛素分泌依赖于新生鼠胰岛中的 FFA1 和 Gq。
Diabetologia. 2023 Aug;66(8):1501-1515. doi: 10.1007/s00125-023-05932-5. Epub 2023 May 23.
4
BRSK2 in pancreatic β cells promotes hyperinsulinemia-coupled insulin resistance and its genetic variants are associated with human type 2 diabetes.BRSK2 在胰腺 β 细胞中促进高胰岛素血症相关的胰岛素抵抗,其遗传变异与人类 2 型糖尿病相关。
J Mol Cell Biol. 2023 Nov 27;15(5). doi: 10.1093/jmcb/mjad033.
5
Effects of adrenergic-stimulated lipolysis and cytokine production on in vitro mouse adipose tissue-islet interactions.肾上腺素刺激脂肪分解和细胞因子产生对体外小鼠脂肪组织-胰岛相互作用的影响。
Sci Rep. 2022 Sep 22;12(1):15831. doi: 10.1038/s41598-022-18262-0.
6
Computational Study of Asian Propolis Compounds as Potential Anti-Type 2 Diabetes Mellitus Agents by Using Inverse Virtual Screening with the DIA-DB Web Server, Tanimoto Similarity Analysis, and Molecular Dynamic Simulation.采用 DIA-DB 网络服务器的反向虚拟筛选、Tanimoto 相似性分析和分子动力学模拟研究亚洲蜂胶化合物作为潜在的 2 型糖尿病治疗药物
Molecules. 2022 Jun 21;27(13):3972. doi: 10.3390/molecules27133972.
7
Cyanidin-3-O-Glucoside Ameliorates Palmitic-Acid-Induced Pancreatic Beta Cell Dysfunction by Modulating CHOP-Mediated Endoplasmic Reticulum Stress Pathways.矢车菊素-3-O-葡萄糖苷通过调节 CHOP 介导的内质网应激通路改善棕榈酸诱导的胰腺β细胞功能障碍。
Nutrients. 2022 Apr 28;14(9):1835. doi: 10.3390/nu14091835.
8
Lipid-Induced Adaptations of the Pancreatic Beta-Cell to Glucotoxic Conditions Sustain Insulin Secretion.脂毒性条件下胰腺β细胞的脂质诱导适应性维持胰岛素分泌。
Int J Mol Sci. 2021 Dec 28;23(1):324. doi: 10.3390/ijms23010324.
9
Metabolic implications of pancreatic fat accumulation.胰腺脂肪堆积的代谢影响。
Nat Rev Endocrinol. 2022 Jan;18(1):43-54. doi: 10.1038/s41574-021-00573-3. Epub 2021 Oct 20.
10
Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators.游离脂肪酸受体及其别构调节剂的药理学。
Int J Mol Sci. 2021 Feb 10;22(4):1763. doi: 10.3390/ijms22041763.
空腹血浆游离脂肪酸水平较高与儿童和成人胰岛素分泌减少以及 2 型糖尿病发病率升高有关。
J Clin Endocrinol Metab. 2012 Sep;97(9):3302-9. doi: 10.1210/jc.2012-1428. Epub 2012 Jun 27.
4
Free fatty acid receptor 1 (FFA1/GPR40) agonists: mesylpropoxy appendage lowers lipophilicity and improves ADME properties.游离脂肪酸受体 1(FFA1/GPR40)激动剂:甲磺酸丙氧基酯附属物降低脂溶性并改善 ADME 性质。
J Med Chem. 2012 Jul 26;55(14):6624-8. doi: 10.1021/jm3002026. Epub 2012 Jul 13.
5
TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial.TAK-875 与安慰剂或格列美脲治疗 2 型糖尿病:一项 2 期、随机、双盲、安慰剂对照试验。
Lancet. 2012 Apr 14;379(9824):1403-11. doi: 10.1016/S0140-6736(11)61879-5. Epub 2012 Feb 27.
6
Identification of a potent and selective free fatty acid receptor 1 (FFA1/GPR40) agonist with favorable physicochemical and in vitro ADME properties.鉴定一种强效和选择性的游离脂肪酸受体 1(FFA1/GPR40)激动剂,具有良好的理化性质和体外 ADME 性质。
J Med Chem. 2011 Oct 13;54(19):6691-703. doi: 10.1021/jm2005699. Epub 2011 Sep 13.
7
Lipotoxicity is glucose-dependent in INS-1E cells but not in human islets and MIN6 cells.脂毒性在 INS-1E 细胞中依赖于葡萄糖,但在人胰岛和 MIN6 细胞中则不是这样。
Lipids Health Dis. 2011 Jul 11;10:115. doi: 10.1186/1476-511X-10-115.
8
Evaluation of fasting state-/oral glucose tolerance test-derived measures of insulin release for the detection of genetically impaired β-cell function.评估空腹状态/口服葡萄糖耐量试验衍生的胰岛素分泌指标,以检测遗传缺陷的β细胞功能。
PLoS One. 2010 Dec 2;5(12):e14194. doi: 10.1371/journal.pone.0014194.
9
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk.新的遗传位点与空腹血糖稳态有关,及其对 2 型糖尿病风险的影响。
Nat Genet. 2010 Feb;42(2):105-16. doi: 10.1038/ng.520. Epub 2010 Jan 17.
10
Discovery of potent and selective agonists for the free fatty acid receptor 1 (FFA(1)/GPR40), a potential target for the treatment of type II diabetes.发现强效且选择性的游离脂肪酸受体1(FFA(1)/GPR40)激动剂,该受体是治疗II型糖尿病的潜在靶点。
J Med Chem. 2008 Nov 27;51(22):7061-4. doi: 10.1021/jm8010178.